InterCure Ltd. announced on June 15, 2026, that it is initiating a strategic review of its medical cannabis opportunities in the United States following federal rescheduling. Additionally, the company completed the initial closing of its acquisition of Botanico. InterCure Ltd. is a medical cannabis company.
